Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsHarvard Pilgrim Step Therapy Prior Auth Policy | O…
    Ask Trek AI about this page
    Currentharvard pilgrim health carePolicy N/A

    Step Therapy Prior Authorization Medical Necessity Guidelines

    Customize your policy alerts

    Sign up for all harvard pilgrim health care policy alerts

    Know when harvard pilgrim health care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy requirements and prior authorization conditions for specified formulary drugs (antidepressants, atypical antipsychotics, inhaled corticosteroids, interferons) for Harvard Pilgrim members. Affects prescribers and pharmacy benefit administrators processing prior authorizations and claims.

    Policy Summary
    Payerharvard pilgrim health care
    PolicyStep Therapy Prior Authorization Medical Necessity Guidelines
    Policy CodePolicy N/A
    Change TypeRoutine review — no material changes
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionProvide evidence of a paid pharmacy claim or physician documentation showing the member filled required Step-1 (or Step-2 where specified) medications within the prior 180 days when requesting Step-2 prior authorization.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4therapeutic categories
    180 dayslookback period
    Step-1 vs Step-2structure
    Emsam, Fetzima, Exxua…example products

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria by Therapeutic Category

    Antidepressants - Coverage Criteria

    Covered when the following step-therapy conditions are met for antidepressant products listed:

    Antidepressant Step-1: Bupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine and venlafaxine ER are on Step-1 and are covered without prior authorization.
    Antidepressant Step-2: Emsam, Fetzima, and Exxua are on Step-2 and will be covered if the member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.180 days

    Evidence may be a paid pharmacy claim or physician documentation.

    Atypical Antipsychotics - Coverage Criteria

    Covered when the following step-therapy conditions are met for atypical antipsychotic products listed:

    Atypical Antipsychotic Step-1: Aripiprazole, lurasidone, olanzapine, olanzapine-fluoxetine, quetiapine, risperidone and ziprasidone are on Step-1 and covered without authorization.
    Atypical Antipsychotic Step-2: Asenapine and Fanapt are on Step-2 and will be covered if the member has filled for one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.180 days

    Evidence may be a paid pharmacy claim or physician documentation.

    Inhaled Corticosteroids - Coverage Criteria

    Covered when the following step-therapy conditions are met for inhaled corticosteroid products listed:

    Inhaled Corticosteroid Step-1: QVAR is on Step-1 and covered without authorization.
    Inhaled Corticosteroid Step-2: Fluticasone (Diskus or HFA) is on Step-2 and will be covered if the member has filled for one or more Step-1 medications within the previous 180 days as evidenced by a paid claim or physician documentation.180 days

    Evidence may be a paid pharmacy claim or physician documentation.

    Interferons - Coverage Criteria

    Covered when the following step-therapy conditions are met for interferon products listed:

    Interferon Step-1: Avonex, Betaseron, and Plegridy are on Step-1 and covered without prior authorization.
    Interferon Step-2: Rebif and Rebif Rebidose are on Step-2 and will be covered if the member has filled for two or more Step-1 interferon medications within the previous 180 days as evidenced by a paid claim or physician documentation.two Step-1 fills within 180 days

    Evidence may be a paid pharmacy claim or physician documentation.

    Definitions

    Step-1 (covered without prior authorization)
    DefinitionAgents listed as Step-1 are covered without prior authorization and are the preferred initial therapies in the category.
    Antidepressant Step-1 examplesBupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine, venlafaxine ER are Step-1 and covered without prior authorization.
    Coverage implicationStep-1 agents are eligible for coverage without prior authorization; no paid claim or physician documentation is required to establish prior use.
    Source guidanceSee Step Therapy Prior Authorization guidelines for antidepressant Step-1 list and coverage status.
    Step-2 (coverage requires evidence of prior fills)
    Definition

    Product-Specific Step Therapy Requirements

    DrugStepCoverage requirement
    Emsam
    Step-2
    Will be covered if the member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.
    DrugStepCoverage requirement
    Fetzima
    Step-2
    Will be covered if the member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.
    Exxua
    Step-2
    Will be covered if the member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.
    DrugStepCoverage requirement
    Asenapine
    Step-2
    Will be covered if the member has filled for one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.
    Fanapt
    Step-2
    Will be covered if the member has filled for one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.
    DrugStepCoverage requirement
    Fluticasone (Diskus/HFA)
    Step-2
    Will be covered if the member has filled for one or more Step-1 medications within the previous 180 days as evidenced by a paid claim or physician documentation.

    Coding and Lookback Period

    Lookback period for prior medication fill
    Lookback period180 days
    Evidence acceptedPaid pharmacy claim or physician documentation demonstrating the member filled the required medication within the 180-day lookback.
    Applies toStep-2 coverage determinations across antidepressants, atypical antipsychotics, inhaled corticosteroids, and interferons as specified per category.
    Number of Step-1 fills required for Interferons
    Interferon Step-1 requirementFor Step-2 interferons (Rebif and Rebif Rebidose), the member must have filled two or more Step-1 interferon medications within the previous 180 days.
    Step-1 interferon examplesAvonex, Betaseron, Plegridy are Step-1 interferons covered without prior authorization.

    Provider Actions and Prior Authorization Requirements

    Prior Authorization

    Step-2 drugs require prior authorization with 180‑day fill evidence

    Certain Step-2 products require prior authorization and will only be approved when the member has evidence of prior fills as specified for the drug class (lookback: 180 days). Approval is contingent on a paid pharmacy claim or physician documentation showing the required Step-1/Step-2 medication fills within the prior 180 days.

    • Applies to Step-2 antidepressants (Emsam, Fetzima, Exxua): member must have filled a Step-1 or Step-2 medication within previous 180 days. [[do not include chunk refs in body]]
    • Applies to Step-2 atypical antipsychotics (Asenapine, Fanapt): member must have filled one or more Step-1 or Step-2 medications within previous 180 days.
    • Applies to Step-2 inhaled corticosteroids (Fluticasone): member must have filled one or more Step-1 medications within previous 180 days.
    • Applies to Step-2 interferons (Rebif, Rebif Rebidose): member must have filled two or more Step-1 interferon medications within previous 180 days.
    Step Therapy

    General step therapy rule: try Step-1 first or document recent use

    Step-1 Initial Therapy

    Step-1 initial therapy

    Step-1 drugs are covered without prior authorization as first-line agents.

    Antidepressant Step-1 list: Bupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine and venlafaxine ER are Step-1 and covered without prior authorization.
    Atypical Antipsychotic Step-1 list: Aripiprazole, lurasidone, olanzapine, olanzapine-fluoxetine, quetiapine, risperidone and ziprasidone are Step-1 and covered without prior authorization.
    Inhaled Corticosteroid Step-1 list: QVAR is Step-1 and covered without prior authorization.
    Interferon Step-1 list: Avonex, Betaseron, and Plegridy are Step-1 and covered without prior authorization.

    Background

    This policy groups select formulary drugs into four therapeutic categories — Antidepressants, Atypical Antipsychotics, Inhaled Corticosteroids, and Interferons — and assigns each drug to either Step-1 or Step-2 within its category. Step-1 agents are the preferred initial therapies and are covered without prior authorization. Step-2 agents require evidence of prior use of Step-1 (or the number of Step-1 fills specified) within a 180-day lookback before coverage is approved, and certain Step-2 products require prior authorization.

    The step-therapy structure is an administrative utilization management tool: for Step-2 coverage the provider must document that the member filled the required Step-1 (or Step-2 where specified) medication(s) within the previous 180 days by supplying a paid pharmacy claim or physician documentation. If that evidence is not provided as specified for the category, coverage for the Step-2 product will be denied.

    Policy Summary
    Payerharvard pilgrim health care
    PolicyStep Therapy Prior Authorization Medical Necessity Guidelines
    Policy CodePolicy N/A
    Change TypeRoutine review — no material changes
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionProvide evidence of a paid pharmacy claim or physician documentation showing the member filled required Step-1 (or Step-2 where specified) medications within the prior 180 days when requesting Step-2 prior authorization.
    SourceLink
    On This Page
    Coverage Criteria by Therapeutic CategoryDefinitionsProduct-Specific Step Therapy RequirementsCoding and Lookback PeriodProvider Actions and Prior Authorization RequirementsStep-1 Initial TherapyBackground
    Agents listed as Step-2 require evidence that the member filled one or more Step-1 (or specified number of Step-1) medications within the prior 180 days to be covered.
    Required evidenceCoverage of Step-2 agents is contingent on a paid pharmacy claim or physician documentation demonstrating the member filled the required Step-1 (or Step-2 where noted) medication(s) within the previous 180 days.
    Examples of Step-2 agentsAntidepressants: Emsam, Fetzima, Exxua; Atypical antipsychotics: Asenapine, Fanapt; Inhaled corticosteroids: Fluticasone (Diskus/HFA); Interferons: Rebif, Rebif Rebidose.
    Coverage ruleCertain Step-2 drugs require prior authorization and will be approved only if the member has filled the specified Step-1/Step-2 medication(s) within the previous 180 days, evidenced by a paid claim or physician documentation.
    Evidence requiredTwo or more paid pharmacy claims or physician documentation within the prior 180 days to support Step-2 interferon coverage.

    Step therapy requires that Step-1 agents (covered without prior authorization) be tried before Step-2 products are covered unless documentation shows the member has used the specified Step-1/Step-2 medication(s) within the prior 180 days as allowed by the policy.

    • Step-1 agents are covered without prior authorization (examples listed per drug class).
    • If paid claim or physician documentation demonstrates prior use within 180 days, Step-2 may be covered without additional trial.
    Documentation Required

    Required evidence for Step-2 coverage: paid claim or physician documentation

    To support Step-2 coverage, the provider must submit evidence of prior medication fills: a paid pharmacy claim or physician documentation demonstrating the member filled the required Step-1 (or Step-2 where specified) medication(s) within the previous 180 days.

    • Acceptable evidence: paid pharmacy claim showing fill within 180 days.
    • Or: physician documentation confirming the member filled the required medication(s) within 180 days.
    Denial Risk

    Denial risk if no prior step therapy evidence within 180 days

    Coverage will be denied if there is no evidence — either a paid pharmacy claim or physician documentation — that the member filled the required Step-1 (or specified number of Step-1) or Step-2 medication(s) within the previous 180 days as required for the drug.

    • Example denials: antidepressant Step-2 (Emsam/Fetzima/Exxua) without a paid claim or documentation of a Step-1/Step-2 fill in past 180 days.
    • Interferon Step-2 (Rebif/Rebif Rebidose) requires documentation of two or more Step-1 fills in prior 180 days; absence of this evidence leads to denial.